The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.
Fan SongHongshi CaiYan LiaoShuojin HuangYaoqi JiangJianfeng LiangNan XieJin-Song HouPublished in: Oral diseases (2021)
Preoperative SIRI can be regarded as a meaningful indicator for poor survival of cT1-2N0 OSCC patients, and it is a promising tool to formulate the best individualized treatment for high-risk patients.